Skip to content
  • Jul 21, 2020
  • News

Pekka Simula joins MediSapiens Board of Directors

MediSapiens is pleased to see Mr. Pekka Simula join its Board of Directors. Pekka is a life sciences and IT professional with well over 20 years of life science experience. Pekka was the founding CEO of Oncos Therapeutics and CEO of Herantis Pharma (IPO in 2014) and is currently the Chairman of Finnish Bioindustries.

Share this article:

Facebook
Twitter
LinkedIn
WhatsApp

More articles

MediSapiens releases 1.2 version of Genomics Software Suite
News18.1.2022
MediSapiens Supports Bayer’s Future Clinical Trial Program (Updated)
News30.6.2021
Happy Holidays from MediSapiens
Articles, News17.12.2021
The Two Major Challenges with Population-Scale Genomic and Rich Clinical Data, and How MediSapiens’ Genomics Software Solution Enables Real-Time Genomic Medicine
Articles17.11.2021
Biotechgate Digital Partnering
Events16.11.2021
MediSapiens and Predicell announce cooperation in RWE and Genomics data for healthcare applications
News21.10.2021
MediSapiens releases 1.1 version of Genomics Software Suite
News2.8.2021
IST Online website has been closed
News6.7.2021
MediSapiens and VEIL.AI announce cooperation in data harmonization and anonymization
News17.6.2021
BCB Medical and MediSapiens announce cooperation for data standardization
News7.6.2021
Bio-Europe Digital, 25-28 October, Online
Events2.6.2021
Bio-IT World Conference and Expo 2021, 20-22 September, Boston
Events2.6.2021
© 2023 GSS Software Suite. All rights reserved.
Go to Top